In8bio Net Worth
In8bio Net Worth Breakdown | INAB |
In8bio Net Worth Analysis
In8bio's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including In8bio's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of In8bio's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform In8bio's net worth analysis. One common approach is to calculate In8bio's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares In8bio's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing In8bio's net worth. This approach calculates the present value of In8bio's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of In8bio's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate In8bio's net worth. This involves comparing In8bio's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into In8bio's net worth relative to its peers.
Enterprise Value |
|
To determine if In8bio is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding In8bio's net worth research are outlined below:
| In8bio Inc generated a negative expected return over the last 90 days | |
| In8bio Inc has high historical volatility and very poor performance | |
| In8bio Inc has some characteristics of a very speculative penny stock | |
| In8bio Inc has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (30.01 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| In8bio Inc currently holds about 25.74 M in cash with (23.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.37, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| In8bio Inc has a poor financial position based on the latest SEC disclosures | |
| Roughly 22.0% of the company shares are held by company insiders | |
| Latest headline from finance.yahoo.com: IN8bio Reports Continued Durable Remissions in Phase 1 Trial of INB-200 in Plenary Oral Presentation at the Society for Neuro-Oncology Annual Meeting |
In8bio uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in In8bio Inc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to In8bio's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 10th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know In8bio's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as In8bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading In8bio Inc backward and forwards among themselves. In8bio's institutional investor refers to the entity that pools money to purchase In8bio's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Blackrock Inc | 2024-06-30 | 57.1 K | Rock Creek Group, Lp | 2024-06-30 | 52.4 K | Overbrook Management Corp | 2024-09-30 | 33.8 K | Northern Trust Corp | 2024-09-30 | 30 K | Lpl Financial Corp | 2024-09-30 | 12.3 K | Westside Investment Management, Inc. | 2024-06-30 | 12 K | Hrt Financial Llc | 2024-06-30 | 10.8 K | Hightower Advisors, Llc | 2024-06-30 | 10 K | Tower Research Capital Llc | 2024-06-30 | 3.8 K | Aigh Capital Management, Llc | 2024-09-30 | 1.7 M | Vanguard Group Inc | 2024-09-30 | 1.4 M |
Follow In8bio's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 22.09 M.Market Cap |
|
Project In8bio's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.89) | (0.93) | |
| Return On Capital Employed | (1.07) | (1.12) | |
| Return On Assets | (0.89) | (0.93) | |
| Return On Equity | (1.20) | (1.14) |
When accessing In8bio's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures In8bio's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of In8bio's profitability and make more informed investment decisions.
Please note, the presentation of In8bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, In8bio's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of In8bio's management manipulating its earnings.
Evaluate In8bio's management efficiency
In8bio Inc has return on total asset (ROA) of (0.7764) % which means that it has lost $0.7764 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.8045) %, meaning that it created substantial loss on money invested by shareholders. In8bio's management efficiency ratios could be used to measure how well In8bio manages its routine affairs as well as how well it operates its assets and liabilities. As of December 1, 2024, Return On Tangible Assets is expected to decline to -0.93. In addition to that, Return On Capital Employed is expected to decline to -1.12. At present, In8bio's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 687.7 K, whereas Total Assets are forecasted to decline to about 25.1 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.83 | 0.75 | |
| Tangible Book Value Per Share | 0.83 | 0.75 | |
| Enterprise Value Over EBITDA | (0.87) | (0.91) | |
| Price Book Value Ratio | 1.65 | 1.74 | |
| Enterprise Value Multiple | (0.87) | (0.91) | |
| Price Fair Value | 1.65 | 1.74 | |
| Enterprise Value | 24.8 M | 39.9 M |
Evaluating the management effectiveness of In8bio allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The In8bio Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Return On Equity (1.80) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific In8bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on In8bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases In8bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
In8bio time-series forecasting models is one of many In8bio's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary In8bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
In8bio Earnings per Share Projection vs Actual
In8bio Corporate Management
| Pharm MPH | VP Communications | Profile | |
| TaiWei Ho | President, CoFounder | Profile | |
| William Ho | President, CoFounder | Profile | |
| Trishna MD | Chief Officer | Profile | |
| Kate Rochlin | Chief Officer | Profile | |
| Lawrence Lamb | CoFounder VP | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in In8bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of In8bio. If investors know In8bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about In8bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.74) | Return On Assets (0.78) | Return On Equity (1.80) |
The market value of In8bio Inc is measured differently than its book value, which is the value of In8bio that is recorded on the company's balance sheet. Investors also form their own opinion of In8bio's value that differs from its market value or its book value, called intrinsic value, which is In8bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because In8bio's market value can be influenced by many factors that don't directly affect In8bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between In8bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if In8bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, In8bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.